MIRA
INFORM REPORT
|
Report Date : |
06.08.2011 |
IDENTIFICATION DETAILS
|
Name : |
BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
407-408, Sharda Chambers, New Marine Lines, Mumbai – 400 020, |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as
on) : |
31.03.2010 |
|
|
|
|
Date of
Incorporation : |
24.09.2002 |
|
|
|
|
Com. Reg. No.: |
11-137329 |
|
|
|
|
Capital Investment
/ Paid-up Capital : |
Rs.5.000
millions |
|
|
|
|
CIN No.: [Company Identification
No.] |
U24230MH2002PTC137329 |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
MUMB11832C MUMB10340B |
|
|
|
|
PAN No.: [Permanent Account No.] |
AABCB9286B |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business
: |
Manufacturer and Trader of Pharmaceutical Raw Material, they do
manufacturing through job work. |
|
|
|
|
No. of Employees
: |
35 (Approximately) |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba (51) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 704000 |
|
|
|
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a well established and a reputed company having fine track.
Financial position of the company appears to be sound. Directors are reported
to be experienced and respectable businessmen. Trade relations are reported
as fair. Business is active. Payments are reported to be regular and as per
commitments. The company can be considered normal for business dealings at usual
trade terms and conditions. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
INFORMATION PARTED BY (General Details)
|
Name : |
Mr. Rajesh Massani |
|
Designation : |
Account Manager |
|
Contact No.: |
91-9821231797 |
|
Date : |
05.08.2011 |
LOCATIONS
|
Registered Office/ Corporate Head Quarter : |
407-408, Sharda Chambers, New Marine Lines, Mumbai – 400 020, |
|
Tel. No.: |
91-22-40560560 (30 Lines) |
|
Mobile No.: |
91-9821231797 (Mr. Rajesh Massani) |
|
Fax No.: |
91-22-40560555 |
|
E-Mail : |
|
|
Website : |
|
|
Area : |
1000 sq ft |
|
Location : |
Owned |
|
|
|
|
Administrative Office/ Factory : |
603-A, Dalmal Chambers, 29 New Marine Lines, Mumbai – 400 020, |
|
Tel. No.: |
91-22-66346502/ 66346503 |
|
|
|
|
Warehouse : |
Bhiwandi, Near |
|
Area : |
3000 sq ft |
|
Location : |
Leased |
|
|
|
|
Regional Office : |
Located at: v
Ahmedabad |
|
|
|
|
Factory / Sites : |
Located at: v
v
|
DIRECTORS
As on 30.09.2010
|
Name : |
Mr. Dharmesh Mahendra Shah |
|
Designation : |
Managing Director |
|
Address : |
2301, |
|
Date of Birth/Age : |
15.03.1966 |
|
Qualification : |
Chemical Engineer |
|
Date of Appointment : |
24.09.2002 |
|
DIN No.: |
00452961 |
|
|
|
|
Name : |
Mr. Vijay Chabildas Shah |
|
Designation : |
Director |
|
Address : |
501, Panchsheel, 5th Floor, ‘C’ Road, Churchgate, Mumbai –
400 020, |
|
Date of Birth/Age : |
19.02.1945 |
|
Date of Appointment : |
05.01.2004 |
|
DIN No.: |
00453308 |
|
|
|
|
Name : |
Mr. Suresh Chabildas Shah |
|
Designation : |
Director |
|
Address : |
57, Surya Kiran, 551, Pan Gully, August Kranti Marg, Mumbai – 400 036,
|
|
Date of Birth/Age : |
23.02.1947 |
|
Date of Appointment : |
05.01.2004 |
|
DIN No.: |
00477470 |
|
|
|
|
Name : |
Mr. Tejas Vijay Shah |
|
Designation : |
Director |
|
Address : |
Room No. A29 B 51-52, |
|
Date of Birth/Age : |
11.08.1978 |
|
Date of Appointment : |
16.01.2008 |
|
DIN No.: |
01862033 |
|
|
|
|
Name : |
Mrs. Binita Dharmesh Shah |
|
Designation : |
Director |
|
Address : |
FLR 23, R.N. 2301-2302, Sterline Towers, Goregaonkar Road, LOC
53-9314, Mumbai – 400 007, Maharashtra, India |
|
Date of Birth/Age : |
20.05.1966 |
|
Date of Appointment : |
24.09.2002 |
|
Date of Ceasing : |
10.05.2008 |
|
DIN No.: |
00516101 |
KEY EXECUTIVES
|
Name : |
Mr. Rajesh Massani |
|
Designation : |
Account Manager |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
As on 30.09.2010
|
Names of Shareholders |
|
No. of Shares |
|
Dharmesh M. Shah |
|
4900 |
|
Binita D. Shah |
|
347900 |
|
Sharmishta M Shah |
|
147000 |
|
Suresh C. Shah |
|
100 |
|
Vijay C. Shah |
|
100 |
|
Total |
|
500000 |
As on 30.09.2010
|
Equity Share Breakup |
|
Percentage of Holding |
|
Category |
|
|
|
Directors
or relatives of directors |
|
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer and Trader of Pharmaceutical Raw Material, they do manufacturing
through job work. |
|
|
|
|
Products : |
·
API ·
Finished Formulations ·
Lyphilised Products ·
Biotech Products ·
Intermediate Products |
|
|
|
|
Exports : |
|
|
Products : |
Pharmaceutical Raw Material |
|
Countries : |
v
v
v
v
v
v
v
|
|
|
|
|
Imports : |
|
|
Products : |
Pharmaceutical Raw Material |
|
Countries : |
v
v
v
|
|
|
|
|
Terms : |
|
|
Selling : |
Credit and Advance TT, DA |
|
|
|
|
Purchasing : |
L/C and Advance TT, DA |
GENERAL INFORMATION
|
Suppliers : |
v
Rantus Pharma Private Limited v
R.B. Pharmaceuticals S.A.S. v
RPG Life Sciences Limited, Mumbai v
Shilpa Medicare Limited (L.L.) v
Suman Lifescience (L.L) v
Vital Laboratories Private Limited v
Zhuhai United Laboratories Company Limited v
Virdev Intermediates Private Limited, v
Sharon Bio-Medicine Limited v
Vinayak Printers v
Scube Pharmachem Limited |
|||||||||
|
|
|
|||||||||
|
Customers : |
Manufacturer v
Alkem Laboratories v
Ankur Drugs and Pharma Limited v
Celon Laboratories Limited v
Delta Farma SA v
Dr. Reddy’s Laboratories Limited v
Cadila Healthcare Limited v
Chem Pharm v
LAD Aspen v
Suman Life Sciences v
Sanco Chemicals Private Limited v
Ranbaxy Laboratories Limited, v
Maple Pharmaceuticals Private Limited v
Lupin Limited, v
Lupin Limited, v
Lupin Limited R and D v
Lyka Labs Limited (DR) v
Orbit Impex
|
|||||||||
|
|
|
|||||||||
|
No. of Employees : |
35 (Approximately) |
|||||||||
|
|
|
|||||||||
|
Bankers : |
v
ABN Amro Bank N.V., 7th Floor, Sakhar
Bhavan, Nariman Point, Mumbai – 400 021, v
IDBI Bank, v
Royal Bank of |
|||||||||
|
|
|
|||||||||
|
Facilities : |
|
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
Lalit Mehta and Company Chartered Accountants |
|
Address : |
101, Apollo Arcade, R.K. Singh Marg, Off |
|
Tel. No.: |
91-22-28395987 |
|
PAN No.: |
AABPM6331K |
|
|
|
|
Associates : |
v
Mepro Laboratories v
Mepro Pharmaceuticals Private Limited v
BDR Life Science Private Limited v
Innova Life Sciences Private Limited v
Sunshine Organics Private Limited v
Virdev Intermediates Private Limited v
B.K. Life Sciences Private Limited v
Bini Chemicals and Pharmaceuticals Private
Limited v
MJ Chempharm Private Limited (merged with BDR
Life Science Private Limited) |
CAPITAL STRUCTURE
As on 30.09.2010
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
1000000 |
Equity Shares |
Rs.10/- each |
Rs.10.000 millions |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
500000 |
Equity Shares |
Rs.10/- each |
Rs.5.000
millions |
|
|
|
|
|
As on 31.03.2010
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
500000 |
Equity Shares |
Rs.10/- each |
Rs.5.000
millions |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
500000 |
Equity Shares |
Rs.10/- each |
Rs.5.000
millions |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2010 |
31.03.2009 |
31.03.2008 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
5.000 |
5.000 |
5.000 |
|
|
2] Share Application Money |
0.000 |
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
171.109 |
137.804 |
110.758 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
0.000 |
|
|
NETWORTH |
176.109 |
142.804 |
115.758 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
0.000 |
0.000 |
0.000 |
|
|
2] Unsecured Loans |
9.596 |
12.837 |
48.745 |
|
|
TOTAL BORROWING |
9.596 |
12.837 |
48.745 |
|
|
DEFERRED TAX LIABILITIES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
185.705 |
155.641 |
164.503 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
6.036 |
3.023 |
2.003 |
|
|
Capital work-in-progress |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
INVESTMENT |
74.775 |
74.775 |
74.775 |
|
|
DEFERREX TAX ASSETS |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
116.864
|
28.335 |
39.538 |
|
|
Sundry Debtors |
427.039
|
339.794 |
311.490 |
|
|
Cash & Bank Balances |
157.096
|
98.393 |
69.880 |
|
|
Other Current Assets |
0.030
|
0.205 |
0.095 |
|
|
Loans & Advances |
42.046
|
70.540 |
52.444 |
|
Total
Current Assets |
743.075
|
537.267 |
473.447 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditors |
599.452 |
401.768 |
342.403 |
|
|
Other Current Liabilities |
4.920
|
0.000 |
0.000 |
|
|
Provisions |
33.809
|
57.656 |
43.319 |
|
Total
Current Liabilities |
638.181
|
459.424 |
385.722 |
|
|
Net Current Assets |
104.894
|
77.843 |
87.725 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
185.705 |
155.641 |
164.503 |
|
PROFIT & LOSS ACCOUNT
|
|
PARTICULARS |
31.03.2010 |
31.03.2009 |
31.03.2008 |
|
|
|
SALES |
|
|
|
|
|
|
|
Income |
915.159 |
794.514 |
746.511 |
|
|
|
Other Income |
22.741 |
24.115 |
11.316 |
|
|
|
TOTAL (A) |
937.900 |
818.629 |
757.827 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Cost of Materials |
868.224 |
632.826 |
627.916 |
|
|
|
Operating and Other Expenses |
95.555 |
124.660 |
91.342 |
|
|
|
Preliminary Expenses |
0.000 |
0.000 |
0.020 |
|
|
|
Increase/(Decrease) in Finished Goods |
(88.529) |
11.203 |
(6.649) |
|
|
|
TOTAL (B) |
875.250 |
768.689 |
712.629 |
|
|
|
|
|
|
|
|
Less |
PROFIT
BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B) (C) |
62.650 |
49.940 |
45.198 |
|
|
|
|
|
|
|
|
|
Less |
INTEREST &
FINANCIAL EXPENSES (D) |
6.367 |
7.302 |
4.259 |
|
|
|
|
|
|
|
|
|
|
PROFIT
BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E) |
56.283 |
42.638 |
40.939 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION (F) |
0.733 |
0.468 |
0.312 |
|
|
|
|
|
|
|
|
|
|
PROFIT BEFORE
TAX (E-F) (G) |
55.550 |
42.170 |
40.627 |
|
|
|
|
|
|
|
|
|
Less |
TAX (H) |
22.582 |
15.125 |
11.533 |
|
|
|
|
|
|
|
|
|
|
PROFIT AFTER TAX
(G-H) (I) |
32.968 |
27.045 |
29.094 |
|
|
|
|
|
|
|
|
|
Add |
PREVIOUS
YEARS’ BALANCE BROUGHT FORWARD |
137.803 |
110.758 |
81.664 |
|
|
|
|
|
|
|
|
|
|
BALANCE CARRIED
TO THE B/S |
170.771 |
137.803 |
110.758 |
|
|
|
|
|
|
|
|
|
|
EARNINGS IN
FOREIGN CURRENCY |
|
|
|
|
|
|
|
Exports of Materials |
488.403 |
400.640 |
NA |
|
|
TOTAL EARNINGS |
488.403 |
400.640 |
NA |
|
|
|
|
|
|
|
|
|
|
Earnings Per
Share (Rs.) |
65.94 |
54.09 |
58.19 |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2010 |
31.03.2009 |
31.03.2008 |
|
PAT / Total Income |
(%) |
3.52
|
3.30 |
3.84 |
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
6.07
|
5.31 |
5.44 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
7.42
|
7.81 |
8.54 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.32
|
0.30 |
0.35 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
3.68
|
3.31 |
3.75 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
1.16
|
1.17 |
1.23 |
LOCAL AGENCY FURTHER INFORMATION
Details of Sundry Creditors:
|
Particulars |
31.03.2010
|
31.03.2009
|
31.03.2008 (Rs. in millions) |
|
Sundry Creditors
for Expenses |
46.295 |
401.768 |
342.403 |
|
Sundry Creditors
for Goods |
553.157 |
|
|
|
|
599.452 |
401.768 |
342.403 |
Note:
The Registered Office of the company has been change from 603-A, Dalamal
Chambers, New Marine Lines, 6th Road, Mumbai – 400 020, Maharashtra
to the present address w.e.f. 01.11.2007.
OPERATIONS:
During the year, the Company has made profit of Rs.55.659 millions after
depreciation and before Taxation after making a provision of tax of Rs.19.000
millions and after Debit of Deferred Tax and Short Provision of Income Tax of
Earlier Years net profit of Rs.33.077 millions is Carried to Balance Sheet.
TRADE REFERENCES:
v
Aurbindo Pharma Limited,
v
Abhot Healthcare Limited, Mumbai
FORM 8:
|
Corporate
identity number of the company |
U24230MH2002PTC137329 |
|
Name of the
company |
BDR Pharmaceuticals International Private Limited |
|
Address of the
registered office or of the principal place of business in |
603-A, Dalmal Chambers, 29 New Marine Lines, Mumbai – 400 020, |
|
This form is for |
Creation of
charge |
|
Type of charge |
Hypothecation |
|
Particular of
charge holder |
ABN Amro Bank N V 7th Floor, Sakhar Bhavan, Nariman Point, Mumbai – 400 021, |
|
Nature of
instrument creating charge |
Facility cum
Hypothecation Agreement |
|
Date of
instrument Creating the charge |
15.03.2006 |
|
Amount secured by
the charge |
Rs.70.000
millions |
|
Brief of the
principal terms an conditions and extent and operation of the charge |
·
The
book-debts, assets, stock hypothecated by way of first charge as security for
the payment to the Bank of all monies at any time due and payable by the
Company to the Bank upto Rs.70.000 millions ·
The
Company shall pay all rents, rates, taxes outgoings and other charges in
respect of godowns and other premises in which the Hypothecated Assets are
stored or may be kept. |
|
Description of
the property charged indicating whether it is a charged on |
·
Stock
in trade ·
Book
Debts |
|
Particulars of
the property charged |
First charge over
all book debts of the Borrower and all other movable assets of the Borrower
stocks and book debts of the company (present and future) and all other
tangible movable properties of the Borrower such as raw materials, stocks,
spares, semi-finished and finished goods, goods in process of manufacture and
all goods manufactured therefrom, all such tangible movable properties
belonging to the Borrower which now are, or hereafter from time to time
during the subsistence of the security hereby created be brought in or stored
in or about the Borrower’s factories, premises, warehouses and godowns,
including any such goods in the course of transit or delivery and goods lying
with third parties belonging to the Borrower all of which goods and other
movable assets. |
|
Corporate
identity number of the company |
U24230MH2002PTC137329 |
|
Name of the
company |
BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED |
|
Address of the
registered office or of the principal place of business in |
603-A, Dalmal Chambers, 29 New Marine Lines, Mumbai – 400 020, |
|
This form is for |
Modification of
charge |
|
Type of charge |
·
Book
debts ·
Movable
property (not being pledge) ·
Floating
charge |
|
Particular of
charge holder |
ABN Amro Bank N V, 7th Floor, Sakhar Bhavan, Nariman Point,
Mumbai – 400 021, |
|
Nature of
instrument creating charge |
Supplemental
facility cum Hypothecation Agreement |
|
Date of
instrument Creating the charge |
02.11.2006 |
|
Amount secured by
the charge |
Rs.90.000
millions |
|
Brief of the
principal terms an conditions and extent and operation of the charge |
·
Rate
of interest At negotiated rates ·
Terms
of repayment On Demand ·
Margin As per sanction letter Ref No. CDU/06/1649 dated 10.10.2006 ·
Extent
and operation of the charge The Book-debts, assets, stock hypothecated, by way of first charge, as
security for the payment to the Bank of all monies at any time due and
payable by the Company to the Bank. |
|
Particulars of
the property charged |
All book debts
and the tangible movable properties of the Borrower including raw materials,
stocks, spares, semi-finished and finished goods, goods in process of
manufacturer and all goods manufactured therefrom belonging to the Borrower
which now are or hereafter from time to time during the subsistence of the
security hereby created be brought the Borrower’s factories, premises,
warehouses and godowns including any such goods in the course of transit or
delivery. |
|
Particulars of
the present modification |
At the request of
the Borrower the bank has agreed to increase the facilities from Rs.70.000
millions to Rs.90.000 millions. |
CONTINGENT
LIABILITY: (As on 31.03.2010)
v
Letter of Credit Outstanding – Rs.4.330 millions
v
Bank Guarantee – Rs.0.100 million
FIXED ASSETS:
v Air Conditioner
v Air Conditioner (Ahemdabad)
v Computers
v Motor Car
v Office Equipment
v Computer Software
v Xerox Machine
v Computer Software
v Air Cooler
v Furniture and Fixture
v Furniture and Fixture (Ahemdabad)
v Printer
v Television Set
v Plant and Machinery
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is or
was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No available
information exist that suggest that subject or any of its principals have been
formally charged or convicted by a competent governmental authority for any
financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on Corporate
Governance to identify management and governance. These factors often have been
predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.44.80 |
|
|
1 |
Rs.72.85 |
|
Euro |
1 |
Rs.63.11 |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
5 |
|
PAID-UP CAPITAL |
1~10 |
5 |
|
OPERATING SCALE |
1~10 |
6 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
6 |
|
--PROFITABILIRY |
1~10 |
6 |
|
--LIQUIDITY |
1~10 |
6 |
|
--LEVERAGE |
1~10 |
5 |
|
--RESERVES |
1~10 |
6 |
|
--CREDIT LINES |
1~10 |
6 |
|
--MARGINS |
-5~5 |
- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
NO |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
51 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
- |
NB |
New Business |
- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.